Drug Monitoring, Oxycodone, Screen, Urine : 39363

QOXYU or 39363

Prescription Drug Monitoring, Pain Management

Preferred Specimen
20 mL urine
  
Minimum Volume
5 mL

Room temperature.

Room temperature: 14 days; Refrigerated: 14 days; Frozen: 30 days

Preserved samples

Monday - Saturday

2-3 days (From receipt at performing laboratory)

Oxycodone     <100 ng/mL

Oxycodone is a semisynthetic narcotic analgesic that is available in oral formulations, often in combination with other drugs such as acetaminophen. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of oxycodone and its metabolite oxymorphone is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes strategies as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.